3654 results for «209»

Filter By

3654 results

Rapid-Fire - Rare and unusual (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...

Rapid-Fire - Rare and unusual (Part 1)

How to establish a mitral TEER programme

24 Nov 2024 – From PCR London Valves 2024

Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.

Learn how to find your first cases, select the right...

How to establish a mitral TEER programme

TAVI innovations: latest breakthroughs from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Featured research - Aortic valve (Part 3)

24 Nov 2024 – From PCR London Valves 2024

Featured research - Aortic valve (Part 3)

Featured cases - TAVI-in-TAVI (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Featured cases - TAVI-in-TAVI (Part 1)

Tricuspid valve intervention - Current devices and future perspectives

24 Nov 2024 – From PCR London Valves 2024

Curious about how to tackle the challenges of tricuspid valve interventions? This video dives into the latest devices and strategies, showing you how to select the right approach for each patient.

Watch experienced practitioners treat real-world cases, from atrial functional regurgitation to large annulus gaps and complex...

Tricuspid valve intervention - Current devices and future perspectives

Featured research - Aortic valve (Part 4)

24 Nov 2024 – From PCR London Valves 2024

Featured research - Aortic valve (Part 4)

Featured research - Mitral valve (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Explore the cutting edge of mitral valve research in this two-part featured research session. Dive into a diverse array of abstracts selected from the upcoming PCR London Valves 2024 conference, covering topics such as optimizing neo-left ventricular outflow tract area, addressing anatomical challenges in TMVR, the...

Featured research - Mitral valve (Part 1)

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?